Determination of faropenem in human plasma and urine by liquid chromatography-tandem mass spectrometry

Biomedical Chromatography

Volumn 22, Issue 1, 2008, Pages 5-12

  Gao, Shouhong ^a   Chen, Wansheng ^a   Tao, Xia ^a   Miao, Haijun ^a   Yang, Shaolin ^b   Wu, Rong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Shanghai Construction Group Co   (China)

Author keywords

Faropenem; LC MS MS; Pharmacokinetics

Indexed keywords

ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN);

ELECTROSPRAY TANDEM MASS SPECTROMETRY; FAROPENEM; HUMAN PLASMAS; HUMAN URINE; LIQUID CHROMATOGRAPHY ELECTROSPRAY; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; QUANTITATIVE DETECTION; SIMPLE++;

PHARMACOKINETICS;

ACETONITRILE; CEFALEXIN; FORMIC ACID; FROPENEM; METHANOL; PLASMA PROTEIN;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; DRUG URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRECIPITATION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; URINALYSIS; VOLUNTEER;

EID: 38749145111     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.886     Document Type: Article

References (4)

1. Finch R. Community-acquired pneumonia: the evolving challenge. Clinical Microbiology and infection 2001; 3(7 suppl.): 30-38.
2. Marchese A, Debbia EA, Bryskier A and Schito GC. Antimicrobial activity of faropenem, a new oral penem, against lower respiratory tract pathogens. Clinical Microbiology and Infection 1999; 5: 282-287.
3. Nirogi RV, Kandikere VN, Shrivastava W and Mudigonda K. Quantification of faropenem in human plasma by high-performance liquid chromatography. Arzneimittelforschung 2005; 55(12): 762-766.
4. Woodcock JM, Andrews JM, Brenwald NP, Ashby JP and Wise R. The in-vitro activity of faropenem, a novel oral penem. Journal of Antimicrobial Chemotherapy 1997; 39: 35-43.